Reflexões sobre o uso das vacinas para COVID-19 em crianças e adolescentes

Lima, Eduardo Jorge da Fonseca; Faria, Sônia Maria de; Kfouri, Renato de Ávila

doi:10.1590/s1679-49742021000400028

Cited by 5 publications

(2 citation statements)

References 8 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Estimates show that currently, about 29% of the Brazilian population is under 20 years old, and 61% of adolescents between 12 and 17 years old are completely immunized, while only 9% of children between 5 and 11 years old have been vaccinated, urging the encouragement of vaccination. Morbidity and mortality related to COVID-19 have short, medium, and/or long-term consequences 41 , which may compromise the health of children and adolescents 42 , interfering with their integral development, adequate socialization, school performance, and, in the future, their full insertion into society. As a result, the vaccine is recommended as protection.…”

Section: Final Considerationsmentioning

confidence: 99%

Multisystem Inflammatory Syndrome and COVID-19 in children and adolescents: epidemiological aspects, Brazil, 2020-20211

et al. 2022

View full text Add to dashboard Cite

This study describes epidemiological aspects of the Multisystemic Inflammatory Syndrome in Children (MIS-C) associated with COVID-19 and mortality by COVID-19 in children (0-9 years old) and adolescents (10-19 years old). The data sources, for 2020-2021, were the Epidemiological Surveillance System for MIS-C and Mortality Information System for COVID-19, both managed by the Ministry of Health. There were 1,503 cases, more frequent in children (77%) than in adolescents (23%), and 93 reported deaths due to MIS-C in 26 of the 27 States of the Country. The highest number of cases in children was reported in São Paulo (268), but the highest incidence took place in the Federal District (7.8 per 100,000 inhabitants). The rate of deaths due to MIS-C was 5.4% in children and 8.7% in adolescents. There were 2,329 deaths due to COVID-19 in the population under 20 years old, with a higher rate in adolescents (4.4 per 100,000 inhabitants) than in children (2.7); the highest rate occurred in Roraima. We recommend intensifying immunization against COVID-19 in such population, increasing protection against the negative effects of COVID-19 and MIS-C, which may have short, medium and/or long-term consequences, so as not to compromise the full integration of these citizens into society.

show abstract

Section: Final Considerationsmentioning

confidence: 99%

Multisystem Inflammatory Syndrome and COVID-19 in children and adolescents: epidemiological aspects, Brazil, 2020-20211

et al. 2022

View full text Add to dashboard Cite

show abstract

“…No Brasil, a vacina produzida pela Pfi zer-BioNTech com tecnologia de RNA mensageiro (RNam) foi aprovada pela ANVISA para uso de adolescente com 12 anos ou mais. A vacinação de adolescentes tem impacto direto na redução da transmissão comunitária de COVID-19, proporcionando retorno seguro para atividades escolares e sociais (Lima et al, 2021). No entanto, a hesitação para vacinação de crianças segue como agenda fundamental, com polarização de opiniões, atrasando a tomada de decisão sobre políticas de proteção e cuidados em saúde com as crianças.…”

unclassified

Hesitação à Vacina de COVID-19 para Crianças no Brasil

Campos¹,

Santana²,

Silva³

et al. 2022

Cad. Psic.

View full text Add to dashboard Cite

Currently, one of the most effective strategies in the fi ght against COVID-19 is vaccination. With an expressive number of vaccinated in Brazil, specialists and Brazilian Health Regulatory Agency (ANVISA) present as a national vaccination plan the use of immunizations for children, which has caused a certain strangeness and hesitation on the part of those responsible and has divided opinions among the population as a whole. It is known that many opinions are the result of political and ideological positions and that they are in favor or against vaccination. Some groups present arguments that defend the immediate vaccination of children and another that maintains possible damages to health that can lead to psychological and physical consequences, in addition to deeming unnecessary. This work seeks to answer the following question: does the perception of risk and benefi t of vaccination against COVID-19 affect the attitude of parents or guardians to vaccinate their children? Thus, the main objective is to analyze the vaccination of children through the perception of risks or benefi ts and whether factors such as gender, education and sharing residence with children affect the decision to hesitate before vaccinating. The research had 293 participants, of both sexes (M=36.5% and F=63.5%), with an average age of 38 years, distributed in 17 Brazilian states. After statistical analysis, it was found that gender is not a signifi cant variable for the decision to vaccinate children, as well as schooling and he fact of living with the child. However, a signifi cant correlation was found between the perception of benefi t (p=.016) and risk (p=.001) and the decision to vaccinate, with the perception of risk being more determinant in the attitude of hesitation .Keyword: pandemic, vaccine, children, immunization, hesitation.

show abstract

Estratégias dos municípios mineiros para aumentar a cobertura vacinal de crianças contra a COVID-19

Lachtim,

Paiva,

Freitas

et al. 2023

Revista Da Sociedade Brasileira De Enfermeiros Pediatras

View full text Add to dashboard Cite

Reflexões sobre o uso das vacinas para COVID-19 em crianças e adolescentes

Abstract: Reflections on the use of COVID-19 vaccines in children and adolescentsReflexiones sobre el uso de vacunas contra la COVID-19 en niños y adolescentes

Cited by 5 publications

References 8 publications

Multisystem Inflammatory Syndrome and COVID-19 in children and adolescents: epidemiological aspects, Brazil, 2020-20211

Multisystem Inflammatory Syndrome and COVID-19 in children and adolescents: epidemiological aspects, Brazil, 2020-20211

Hesitação à Vacina de COVID-19 para Crianças no Brasil

Estratégias dos municípios mineiros para aumentar a cobertura vacinal de crianças contra a COVID-19

Contact Info

Product

Resources

About